ArticleSurgical endoscopy2026
Clinical characteristics of synchronous and metachronous superficial esophageal squamous cell carcinoma during surveillance after endoscopic submucosal dissection.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough endoscopic submucosal dissection (ESD) is the standard treatment for superficial esophageal squamous cell carcinoma (SESCC), the clinical characteristics of synchronous and metachronous (secondary) lesions detected during follow-up remain unclear. This study aimed to compare the clinicopathologic characteristics and outcomes of initial and secondary SESCC lesions.
methodsThis single-center study analyzed 307 esophageal squamous cell carcinoma lesions in 188 patients who underwent ESD as their initial treatment between January 2005 and January 2025. The lesions were categorized as initial (n = 208) or secondary (n = 99) based on their timing of detection. Clinicopathological features and short-term outcomes were compared between the two groups.
resultsPatients with multiple lesions were younger and had a higher prevalence of prior head and neck cancer and a higher prevalence of Lugol-voiding lesion grades B/C. The median time to detection of secondary lesions was 18 months. Secondary lesions were smaller (< 20 mm: 88% vs. 44%) and shallower (epithelial/lamina propria mucosa: 89% vs. 74%) than initial lesions. Multivariate analysis revealed that tumor size < 20 mm (odds ratio 0.12, 95% confidence interval 0.06-0.23) and epithelial/lamina propria mucosa invasion depth (odds ratio 0.37, 95% confidence interval 0.17-0.84) were independently associated with secondary lesions. In secondary lesions, curative resection rates were higher (84% vs. 68%, p < 0.005) and complications less frequent (12% vs. 34%, p < 0.001). Esophageal stenosis occurred less frequently in secondary lesions. The cumulative incidences of secondary lesions were 10.2%, 18.9%, and 28.2% at 1, 3, and 5 years, respectively.
conclusionSecondary SESCC lesions tend to be smaller and shallower, enabling higher curative resection rates and lower complication risks. These findings suggest that secondary lesions are more amenable to curative ESD when detected at an early stage. Regular surveillance after ESD facilitates early detection of secondary lesions and their curative resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.